Christopher qualified in Medicine from the University of Cambridge in 2011, and has since specialised in Infectious Diseases and Microbiology, training in Oxford and Manchester, including an NIHR Academic Clinical Fellowship with the Oxford Vaccine Group working on typhoid human challenge infection models. He is currently nearing completion of a PhD as a recipient of an MRC Clinical Pharmacology Fellowship award at the University of Liverpool. His current research interests are the pharmacodynamics of combination antimicrobials and the repurposing of old off-patent antibiotics for use in neonatal infections, particularly in low- and middle-income countries where antimicrobial resistance Is prevalent.